Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (000766.SZ)
CNY 15.39
(0.33%)
CNY 15.39
(0.33%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.46 Billion | 1.47 Billion | 1.51 Billion | 1.11 Billion | 1.97 Billion | 2.09 Billion |
| Cost of Revenue | 410.35 Million | 353.2 Million | 352.84 Million | 224.3 Million | 339.9 Million | 341.36 Million |
| Gross Profit | 1.05 Billion | 1.11 Billion | 1.16 Billion | 887.5 Million | 1.63 Billion | 1.75 Billion |
| Operating Expenses | 1.03 Billion | 988.51 Million | 1.03 Billion | 1.06 Billion | 1.5 Billion | 1.44 Billion |
| Selling, General and Administrative Expenses | 881.73 Million | 840.65 Million | 908.8 Million | 962.14 Million | 1.36 Billion | 1.29 Billion |
| Research and Development Expenses | 45.82 Million | 64.9 Million | 63.51 Million | 50.32 Million | 66.91 Million | 67.3 Million |
| Other Expenses | - | 82.94 Million | 67.34 Million | 49.42 Million | 78.75 Million | 1.45 Million |
| Cost and Expenses | 1.33 Billion | 1.34 Billion | 1.39 Billion | 1.28 Billion | 1.84 Billion | 1.78 Billion |
| Operating Income | 143.4 Million | 139.16 Million | 146.08 Million | -174.39 Million | 158.67 Million | 407.79 Million |
| Interest Expense | 83.14 Million | 88.79 Million | 97.18 Million | 125.27 Million | 48.79 Million | 42.3 Million |
| Income Tax Expense | 11.62 Million | 20.98 Million | 25.63 Million | 4.82 Million | 30.19 Million | 80.02 Million |
| Earnings before Tax | 54.85 Million | 50.17 Million | 59.62 Million | -355.83 Million | -2.01 Billion | 409.24 Million |
| Net Income | 43.93 Million | 30.15 Million | 35.27 Million | -360.65 Million | -2.04 Billion | 330.85 Million |
| Earnings Per Share Basic | 0.05 | 0.03 | 0.04 | -0.37 | -2.11 | 0.34 |
| Earnings Per Share Diluted | 0.05 | 0.03 | 0.04 | -0.37 | -2.11 | 0.34 |
| Weighted Average Shares Outstanding | 878.67 Million | 966.49 Million | 966.49 Million | 966.49 Million | 966.49 Million | 966.49 Million |
| Weighted Average Shares Outstanding (Diluted) | 878.67 Million | 966.49 Million | 966.49 Million | 966.49 Million | 966.49 Million | 973.11 Million |
| Gross Margin | 0.72 | 0.76 | 0.77 | 0.80 | 0.83 | 0.84 |
| EBIT Margin | 0.15 | 0.14 | 0.14 | -0.07 | 0.11 | 0.20 |
| Profit Margin | 0.03 | 0.02 | 0.02 | -0.32 | -1.03 | 0.16 |
| EBITDA | 217.47 Million | 210.58 Million | 215.47 Million | -154.97 Million | -1.89 Billion | 518.15 Million |
| Earnings Before Tax Margin | 0.10 | 0.09 | 0.10 | -0.16 | 0.08 | 0.19 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 319.4 Million | 351.24 Million | 295.57 Million | 1.46 Billion | 425.74 Million | 315.75 Million |
| Cost of Revenue | 77.59 Million | 88.83 Million | 79.94 Million | 410.35 Million | 127.04 Million | 75.6 Million |
| Gross Profit | 241.8 Million | 262.41 Million | 215.63 Million | 1.05 Billion | 298.7 Million | 240.15 Million |
| Operating Expenses | 210.14 Million | 237.29 Million | 190.51 Million | 928.69 Million | 249.09 Million | 210.79 Million |
| Selling, General and Administrative Expenses | 253.97 Million | 227.09 Million | 184.5 Million | - | 233.55 Million | 247.38 Million |
| Research and Development Expenses | 10.16 Million | 10.2 Million | 7.85 Million | - | 15.85 Million | 8.02 Million |
| Other Expenses | -53.99 Million | -327.24 Thousand | -13.94 Thousand | -2.02 Million | 320.03 Thousand | -387.52 Thousand |
| Cost and Expenses | 287.73 Million | 326.12 Million | 270.45 Million | 1.33 Billion | 376.13 Million | 286.39 Million |
| Operating Income | 12.18 Million | 25.11 Million | 10.87 Million | 123.62 Million | 49.6 Million | 12.03 Million |
| Interest Expense | 21.61 Million | 21.24 Million | 19.01 Million | 83.14 Million | 22.49 Million | 20.66 Million |
| Income Tax Expense | 712.99 Thousand | -479.88 Thousand | 1.69 Million | 11.62 Million | 4.31 Million | 7.1 Million |
| Earnings before Tax | 12.22 Million | 2.7 Million | 10.86 Million | 58.59 Million | 32.68 Million | 11.65 Million |
| Net Income | 11.45 Million | 3.28 Million | 9.18 Million | 43.93 Million | 28.38 Million | 4.77 Million |
| Earnings Per Share Basic | 0.01 | 0.00 | 0.01 | - | 0.03 | 0.00 |
| Earnings Per Share Diluted | 0.01 | 0.00 | 0.01 | - | 0.03 | 0.00 |
| Weighted Average Shares Outstanding | 966.49 Million | 966.49 Million | 966.97 Million | 966.49 Million | 966.49 Million | 966.49 Million |
| Weighted Average Shares Outstanding (Diluted) | 966.49 Million | 966.49 Million | 966.97 Million | 966.49 Million | 966.49 Million | 966.49 Million |
| Gross Margin | 0.76 | 0.75 | 0.73 | 0.72 | 0.70 | 0.76 |
| EBIT Margin | 0.11 | 0.12 | 0.10 | - | 0.16 | 0.11 |
| Profit Margin | 0.04 | 0.01 | 0.03 | 0.03 | 0.07 | 0.02 |
| EBITDA | 33.83 Million | 42.73 Million | 29.76 Million | - | 68.9 Million | 33.2 Million |
| Earnings Before Tax Margin | 0.04 | 0.07 | 0.04 | 0.08 | 0.12 | 0.04 |
SGHT
YJ
ACMT
LGYRF
9236
AMMX